BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ma H, Abdul-Hay M. T-cell lymphomas, a challenging disease: types, treatments, and future. Int J Clin Oncol 2017;22:18-51. [PMID: 27743148 DOI: 10.1007/s10147-016-1045-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Jairath NK, Bardhi R, Runge JS, Bledea R, Jairath R, Wang Y, Patrick M, Wilcox RA, Hristov AC, Tsoi LC, Tejasvi T. Predictors of large cell transformation in patients with Sezary Syndrome-A retrospective analysis. PLoS One 2022;17:e0277655. [PMID: 36383618 DOI: 10.1371/journal.pone.0277655] [Reference Citation Analysis]
2 Mahajan S, Aalhate M, Guru SK, Singh PK. Nanomedicine as a magic bullet for combating lymphoma. J Control Release 2022;347:211-36. [PMID: 35533946 DOI: 10.1016/j.jconrel.2022.05.002] [Reference Citation Analysis]
3 de Pádua Covas Lage LA, Brito CV, Levy D, Culler HF, Freitas Couto SC, de Oliveira LBA, Nogueira Zerbini MC, Rocha V, Pereira J. “Diagnostic and prognostic implications of tumor expression of the GATA-3 gene in nodal peripheral T-cell lymphoma (nPTCL): retrospective data from a Latin American cohort.”. Leukemia Research 2022. [DOI: 10.1016/j.leukres.2022.106794] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Khan SM, Faisal AM, Nila TA, Binti NN, Hosen MI, Shekhar HU. A computational in silico approach to predict high-risk coding and non-coding SNPs of human PLCG1 gene. PLoS One 2021;16:e0260054. [PMID: 34793541 DOI: 10.1371/journal.pone.0260054] [Reference Citation Analysis]
5 Bao W, Buchanan KL, Davis LS. Not your typical morbilliform rash: Angioimmunoblastic T‐cell lymphoma. Clin Case Rep 2021;9. [DOI: 10.1002/ccr3.4367] [Reference Citation Analysis]
6 Reichardt SD, Lühder F, Wiegers GJ, Reichardt HM. A flow cytometric approach to study glucocorticoid receptor expression in immune cell subpopulations of genetically engineered mice. Immunol Lett 2021;233:68-79. [PMID: 33753134 DOI: 10.1016/j.imlet.2021.03.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Falker-Gieske C, Mott A, Franzenburg S, Tetens J. Multi-species transcriptome meta-analysis of the response to retinoic acid in vertebrates and comparative analysis of the effects of retinol and retinoic acid on gene expression in LMH cells. BMC Genomics 2021;22:146. [PMID: 33653267 DOI: 10.1186/s12864-021-07451-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Gajendran B, Varier KM, Liu W, Wang C, Sample KM, Zacksenhaus E, Juiwei C, Huang L, Hao X, Ben-David Y. A C21-steroidal derivative suppresses T-cell lymphoma in mice by inhibiting SIRT3 via SAP18-SIN3. Commun Biol 2020;3:732. [PMID: 33273692 DOI: 10.1038/s42003-020-01458-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
9 Xiong Y, Yang L, Dai J, Zhou F, Zhou Y. Chemotherapy combined with radiotherapy for successful treatment of angioimmunoblastic T-cell lymphoma: a case report. J Med Case Rep 2020;14:185. [PMID: 33046131 DOI: 10.1186/s13256-020-02489-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Jairath NK, Jairath R, Bardhi R, Runge JS, Bledea R, Wang Y, Hristov A, Wilcox RA, Tsoi LC, Patrick M, Tejasvi T. Risk Factors for Large Cell Transformation in Patients with Sezary Syndrome.. [DOI: 10.1101/2020.06.01.20119669] [Reference Citation Analysis]
11 Yadav N, Parveen S, Banerjee M. Potential of nano-phytochemicals in cervical cancer therapy. Clin Chim Acta 2020;505:60-72. [PMID: 32017926 DOI: 10.1016/j.cca.2020.01.035] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 6.7] [Reference Citation Analysis]
12 Cooper ML, DiPersio JF. Chimeric antigen receptor T cells (CAR-T) for the treatment of T-cell malignancies. Best Pract Res Clin Haematol 2019;32:101097. [PMID: 31779968 DOI: 10.1016/j.beha.2019.101097] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
13 Cogan J, E. Amengual J. Unique Therapeutic Approaches for Targeting Epigenetic Machinery in T-cell Lymphoma. Peripheral T-cell Lymphomas 2019. [DOI: 10.5772/intechopen.85059] [Reference Citation Analysis]
14 Leuchte K, Schlaak M, Stadler R, Theurich S, von Bergwelt-baildon M. Innovative Behandlungskonzepte mit Modulation der Mikroumgebung beim kutanen T-Zell-Lymphom. Kompass Dermatol 2019;7:111-119. [DOI: 10.1159/000500890] [Reference Citation Analysis]
15 Scarfò I, Ormhøj M, Frigault MJ, Castano AP, Lorrey S, Bouffard AA, van Scoyk A, Rodig SJ, Shay AJ, Aster JC, Preffer FI, Weinstock DM, Maus MV. Anti-CD37 chimeric antigen receptor T cells are active against B- and T-cell lymphomas. Blood 2018;132:1495-506. [PMID: 30089630 DOI: 10.1182/blood-2018-04-842708] [Cited by in Crossref: 76] [Cited by in F6Publishing: 79] [Article Influence: 15.2] [Reference Citation Analysis]
16 Cooper ML, Choi J, Staser K, Ritchey JK, Devenport JM, Eckardt K, Rettig MP, Wang B, Eissenberg LG, Ghobadi A, Gehrs LN, Prior JL, Achilefu S, Miller CA, Fronick CC, O'Neal J, Gao F, Weinstock DM, Gutierrez A, Fulton RS, DiPersio JF. An "off-the-shelf" fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies. Leukemia 2018;32:1970-83. [PMID: 29483708 DOI: 10.1038/s41375-018-0065-5] [Cited by in Crossref: 187] [Cited by in F6Publishing: 197] [Article Influence: 37.4] [Reference Citation Analysis]
17 Broadwater DR, Peker D. Systemic Non-Hodgkin T Cell Lymphomas Presenting in the Head and Neck Region: An Institutional Experience of a Rare Entity. Head Neck Pathol 2018;12:481-7. [PMID: 29302898 DOI: 10.1007/s12105-017-0881-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
18 Zhao N, Zeng Z, Zu Y. Self-Assembled Aptamer-Nanomedicine for Targeted Chemotherapy and Gene Therapy. Small 2018;14. [PMID: 29205808 DOI: 10.1002/smll.201702103] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]